Licensing deals

liver
Biotech

Madrigal pens $2B deal for CSPC's GLP-1, eyes Rezdiffra pairing

Madrigal is paying $120 million upfront for a preclinical GLP-1 agonist the biopharma plans to pair with its fatty liver disease med Rezdiffra.
James Waldron Jul 30, 2025 7:35am
Three blocks displaying from left to right a person a handshake and another person

Kissei pays Viridian $70M to challenge Amgen for Japanese market

Jul 30, 2025 4:50am
Closeup of blue eye on black background

Boehringer pens $1B pact to reduce eye drug injections

Jul 28, 2025 8:48am
Lung

GSK strengthens COPD offering via $12B biobucks Hengrui deal

Jul 28, 2025 4:36am
blue tennis court with tennis balls and racquets

Matchpoint nets $60M in new Novartis deal

Jul 24, 2025 12:04pm
Uninhabited island full of trees

Galapagos builds island of cell therapies amid pipeline pruning

Jul 24, 2025 10:59am